Chronobiology International · Nov 18, 2026

The chronobiology of brain waste clearance: Sleep-wake and circadian regulation of glymphatic function

By Koynova-Tenchov R

The glymphatic system – a glia-dependent perivascular network mediating cerebrospinal fluid and interstitial fluid exchange – has emerged as a key determinant of restorative sleep, with its efficiency governed by both sleep-wake state and the circadian clock. Its activity peaks during NREM slow-wave sleep and is essential for clearing neurotoxic proteins including amyloid-β and hyperphosphorylated tau, whose accumulation underlies Alzheimer’s disease and related neurodegenerative proteinopathies. This activity is itself under circadian control, with aquaporin-4 expression, CSF production, and perivascular flow exhibiting diurnal rhythmicity driven by the suprachiasmatic clock and peripheral clock genes. Recent work identifying synchronized norepinephrine oscillations from the locus coeruleus as the primary driver of glymphatic vasomotion has reframed the system’s mechanistic architecture and raised questions about sedative-hypnotics and circadian disruption, both of which suppress this oscillatory pattern. This review synthesizes mechanistic, biomarker, and therapeutic evidence into a chronobiological framework positioning glymphatic efficiency as a distinct dimension of sleep quality – one that conventional EEG-based staging fails to capture. We examine disruption of glymphatic function by circadian misalignment, aging, sleep fragmentation, and neurodegeneration, and evaluate emerging biomarkers – including DTI-ALPS and plasma markers of waste accumulation – appraising their validity and limitations. Drawing on a broad literature survey and publication-trend analysis, we identify emerging perspectives to inform targeted therapeutic strategies. The therapeutic landscape is assessed across non-pharmacological, chronotherapeutic, pharmacological, and vascular and meningeal lymphatic interventions. We identify a translational gap between preclinical and human evidence, and propose that glymphatic biomarker endpoints be incorporated into sleep and chronobiology trials as a scientific priority.

doi.org/10.1080/07420528.2026.2765308PubMed 43049879Mechanisms

AgingResearch.News